Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants
Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire November 13, 2025 BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced the pricing […]